Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at the upcoming TD Cowen 44th Annual Health Care Conference in Boston on...
Tuesday, February 27, 2024 1 min read
Key Takeaway: Nektar Therapeutics is set to present at the TD Cowen 44th Annual Health Care Conference in Boston on March 5, 2024. The event will begin at 2:10 p.m. Eastern Time and will include a Q&A session accessible via webcast. This presentation highlights Nektar's ongoing commitment to engaging with investors and providing updates on its development programs.
Market Sentiment Analysis
POSITIVE FACTORS
Nektar will present at a prestigious health care conference
The presentation will include a Q&A session, allowing for audience interaction
The company has a robust R&D pipeline in immunology and oncology
Full Press Release Details
SAN FRANCISCO , Feb. 27, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) management is scheduled to present at the upcoming TD Cowen 44 th Annual Health Care Conference in Boston on Tuesday, March 5, 2024 at 2:10 p.m. Eastern Time .
The presentation and Q&A session will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: https://ir.nektar.com/events-and-presentations/events . This webcast will be available for replay until April 5, 2024 .
About Nektar Therapeutics Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in immunology and oncology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
For Investors: Vivian Wu of Nektar Therapeutics 628-895-0661
For Media: David Rosen of Argot Partners (212) 600-1902 [email protected]
SOURCE Nektar Therapeutics
21 %
Frequently Asked Questions
When is Nektar Therapeutics presenting at the conference?
Nektar Therapeutics will present on March 5, 2024, at 2:10 p.m. ET.
Where can I watch Nektar's presentation and Q&A?
The presentation will be available via webcast on Nektar's Investor Events page.
How long will the webcast be available for replay?
The webcast will be available for replay until April 5, 2024.
What areas does Nektar Therapeutics focus on?
Nektar specializes in immunology and oncology, with a strong R&D pipeline.
Where is Nektar Therapeutics headquartered?
Nektar Therapeutics is headquartered in San Francisco, California.